Literature DB >> 25437045

The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.

Neli Hevir-Kene1, Tea Lanišnik Rižner2.   

Abstract

Estrogens have important roles in the pathogenesis of endometrial cancer. They can have carcinogenic effects through stimulation of cell proliferation or formation of DNA-damaging species. To characterize model cell lines of endometrial cancer, we determined the expression profiles of the estrogen receptors (ERs) ESR1, ESR2 and GPER, and 23 estrogen biosynthetic and metabolic genes, and investigated estrogen biosynthesis in the control HIEEC cell line and the Ishikawa and HEC-1A EC cell lines. HIEEC and Ishikawa expressed all ERs to different extents, while HEC-1A cells lacked expression of ESR1. Considering the estrogen biosynthetic and metabolic enzymes, these cells showed statistically significant different gene expression profiles for SULT2B1, HSD3B2, CYP19A1, AKR1C3, HSD17B1, HSD17B7, HSD17B12, CYP1B1, CYP3A5, COMT, SULT1A1, GSTP1 and NQO2. In these cells, E2 was formed from E1S and E1, while androstenedione was not converted to estrogens. HIEEC and Ishikawa had similar profiles of androstenedione and E1 metabolism, but hydrolysis of E1S to E1 was weaker in Ishikawa cells. HEC-1A cells were less efficient for activation of E1 into the potent E2, but metabolized androstenedione to other androgenic metabolites better than HIEEC and Ishikawa cells. This study reveals that HIEEC, Ishikawa, and HEC-1A cells can all form estrogens only via the sulfatase pathway. HIEEC, Ishikawa, and HEC-1A cells expressed all the major genes in the production of hydroxyestrogens and estrogen quinones, and in their conjugation. Significantly higher CYP1B1 mRNA levels in Ishikawa cells compared to HEC-1A cells, together with lack of UGT2B7 expression, indicate that Ishikawa cells can accumulate more toxic estrogen-3,4-quinones than HEC-1A cells, as also for HIEEC cells. This study provides further characterization of HIEEC, Ishikawa, and HEC-1A cells, and shows that they differ greatly in expression of the genes investigated and in their capacity for E2 formation, and thus they represent different in vitro models.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  17β-Hydroxysteroid dehydrogenases (17β-HSDs, HSD17B); Aldo–keto reductase 1C3 (AKR1C3); Aromatase pathway; Catechol-O-methyl transferase (COMT); Phase I and phase II estrogen metabolism; Sulfatase pathway

Mesh:

Substances:

Year:  2014        PMID: 25437045     DOI: 10.1016/j.cbi.2014.11.015

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  16 in total

1.  Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium.

Authors:  Natalia Ryan; Brian Chorley; Raymond R Tice; Richard Judson; J Christopher Corton
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

2.  Prostaglandin E2 receptor EP1 in healthy and diseased human endometrium.

Authors:  Junyan Zhu; Doris Mayr; Christina Kuhn; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Histochem Cell Biol       Date:  2017-11-13       Impact factor: 4.304

Review 3.  AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders.

Authors:  Trevor M Penning
Journal:  Mol Cell Endocrinol       Date:  2018-09-19       Impact factor: 4.102

Review 4.  The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases.

Authors:  Tea Lanišnik Rižner
Journal:  Front Pharmacol       Date:  2016-02-18       Impact factor: 5.810

5.  The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer.

Authors:  Maša Sinreih; Tamara Knific; Maja Anko; Neli Hevir; Katja Vouk; Aleš Jerin; Snježana Frković Grazio; Tea Lanišnik Rižner
Journal:  Front Pharmacol       Date:  2017-06-23       Impact factor: 5.810

6.  Novel 3D embryo implantation model within macroporous alginate scaffolds.

Authors:  Dganit Stern-Tal; Hanna Achache; Liora Jacobs Catane; Reuven Reich; Tali Tavor Re'em
Journal:  J Biol Eng       Date:  2020-06-30       Impact factor: 4.355

Review 7.  Modeling Endometrial Cancer: Past, Present, and Future.

Authors:  Tom Van Nyen; Cristian P Moiola; Eva Colas; Daniela Annibali; Frédéric Amant
Journal:  Int J Mol Sci       Date:  2018-08-09       Impact factor: 5.923

8.  Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients.

Authors:  Junyan Zhu; Fabian Trillsch; Doris Mayr; Christina Kuhn; Martina Rahmeh; Simone Hofmann; Marianne Vogel; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Oncotarget       Date:  2017-12-09

Review 9.  The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.

Authors:  Tea Lanišnik Rižner; Theresia Thalhammer; Csilla Özvegy-Laczka
Journal:  Front Pharmacol       Date:  2017-06-19       Impact factor: 5.810

10.  Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERβ Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication.

Authors:  Atieh Hajirahimkhan; Obinna Mbachu; Charlotte Simmler; Sarah G Ellis; Huali Dong; Dejan Nikolic; David C Lankin; Richard B van Breemen; Shao-Nong Chen; Guido F Pauli; Birgit M Dietz; Judy L Bolton
Journal:  J Nat Prod       Date:  2018-04-11       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.